Enveric Biosciences ENVB
NASDAQ ENVB
$1.52 +0.08 (+5.80%)
As of: Oct 21, 2026 · 11:33 AM EDT

Enveric Biosciences (ENVB) Revenue (2014 - 2026)

Updated

Enveric Biosciences (ENVB) posted Revenue of $8.48 million for Q3 2020, down 7.3% from $9.15 million a year earlier but up 2.8% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Revenue (2014 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2020, Revenue at Enveric Biosciences was $35.41 million, down 13.9% year-over-year; for FY2019, it was $39.91 million, down 7.2% from FY2018.

  • Annual Revenue shows a four-year compound annual growth rate of 18.5% (FY2015 to FY2019).
  • In prior years, Enveric Biosciences' Revenue was $43 million in FY2018 (-11.5%), $48.59 million in FY2017 (+34.4%), $36.15 million in FY2016 (+78.4%) and $20.26 million in FY2015.
  • Quarterly Revenue has run from a low of $6.69 million in Q2 2016 to a high of $12.53 million in Q3 2017 over five years.
  • On a year-over-year basis, Revenue has declined in each of the last 12 quarters, with an average decline of 10.3% over the last eight quarters.
  • The strongest year-over-year quarter for Revenue in the past five years was Q3 2016, with growth of 125.4%; the weakest was Q2 2020, with a decline of 25.1%.
  • According to Business Quant data, Revenue for the three prior quarters was $8.25 million (Q2 2020), $9.6 million (Q1 2020) and $9.06 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 16.99 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 15.03 Bn
10 Enveric Biosciences 6.08 Mn -15.56 Mn - -292.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -292.00
Mar 31, 2026 -303.00
Dec 31, 2025 -250.00
Sep 30, 2025 274.00
Jun 30, 2025 -132.00
Mar 31, 2025 3,252.00
Dec 31, 2024 -225.00
Sep 30, 2024 -217.00
Jun 30, 2024 51,965.00
Mar 31, 2024 46,196.00
Dec 31, 2023 566.00
Sep 30, 2023 2,237.00
Jun 30, 2023 916.00
Mar 31, 2023 -11.00
Dec 31, 2022 -135.00
Sep 30, 2022 -308.00
Jun 30, 2022 -668.00
Sep 30, 2020 8.48 Mn
Jun 30, 2020 8.25 Mn
Mar 31, 2020 9.60 Mn
API Access

Enveric Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ENVB&period=max&api_key=YOUR_API_KEY